|
|
Article: Kumetrix Enters Into Agreement With Bayer Relating to Blood-Glucose Monitoring Device for Diabetics.
- Article from:
- PR Newswire
- Article date:
- April 24, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Silicon Micro-Needle Device Permits Painless Method to Test Blood
UNION CITY, Calif., April 24 /PRNewswire/ --
Kumetrix, Inc., a privately held medical device company, today announced it has entered into an agreement with Bayer Corporation's Business Group Diagnostics relating to Kumetrix's silicon micro-needle device for diabetic blood glucose monitoring.
Under the terms of the agreement, Kumetrix will provide Bayer exclusive rights to further evaluate the Kumetrix silicon micro-needle technology for commercial application in diabetic blood glucose monitoring. Bayer and Kumetrix contemplate working towards creating additional commercial ...